Skip to main content

Table 1 Characteristic of the evaluated patients with bladder cancer, benign urological diseases and healthy donors

From: Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer

 

No. of urine

Gender

 Male

169

 Female

68

 Bladder cancer

84

pTMN

 pT ≤1

44

 pT ≥2

9

 No information

31

Benign diseases

 BPH

26

 Urinary Stone

5

 Hematuria

4

 OAB

3

 Cyst

2

 Others (NB, XGP)

8

 Healthy donors

105

  1. BPH benign prostate hyperplasia, OAB overactive bladder, NB neurogenic bladder, XGP Xanth pyelonephritis